Cerebral venous thrombosis and factor V Leiden;Trombosis venosa cerebral y factor V de Leiden

Revista de Neurologia

Volumn 43, Issue 1, 2006, Pages 49-50

  Medrano, Vicente ^a   Mallada Frechin J ^a   Fernandez Izquierdo S ^a   Piqueras Rodriguez L ^a  

^a HOSPITAL GENERAL DE ELDA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 7; GUANINE; NADROPARIN; TOPIRAMATE; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5;

ADULT; ANTICOAGULATION; ARTICLE; CASE REPORT; CHILDBIRTH; FEMALE; HEMIANOPIA; HUMAN; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PREGNANCY; TONIC CLONIC SEIZURE; GENETICS; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; POINT MUTATION; VEIN THROMBOSIS;

ADULT; ANTICOAGULANTS; FACTOR V; FEMALE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; POINT MUTATION; PREGNANCY; VENOUS THROMBOSIS;

EID: 33750095927     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4301.2006221     Document Type: Article

References (6)

1. Rosenstingl S, Ruivard M, Melon E, Schaeffer A, Gouault-Heilmann M. Cerebral-vein thrombosis: retrospective study of twenty seven cases. Rev Med Interne 2002: 23: 973-82.
2. Lobato-Salinas Z, Cambra-Lasaosa FJ, Campistol J, Toll-Costa T, Pons-Odena M, Palomeque-Rico A, et al. Mutación del factor V de Leiden como causa de trombosis venosa. Rev Neurol 2004; 38: 136-9.
3. Cushman M. Inherited risk factors for venous thrombosis. Hematology (Am Soc Hematol Educ Program) 2005; 452-7.
4. Lüdemann P, Nabavi DG, Junker R, Wolff E, Papke K, Buchner H, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis. Stroke 1998; 29: 2507-10.
5. Franco E, Gil-Néciga E, Salinas E, Morales R, Martínez E, et al. Trombosis venosa cerebral profunda puerperal. Rev Neurol 1999; 29: 722-4.
6. Sánchez-Marín B, Grasa JM, Latorre A, Montañés MA, García-Erce JA, Torres M, et al. Hipercoagulabilidad hereditaria y adquirida en pacientes con trombosis venosa cerebral. Neurología 2002; 17: 405-9.